Publication | Open Access
Promoter polymorphisms of <i>TOP2A</i> and <i>ERCC1</i> genes as predictive factors for chemotherapy in non‐small cell lung cancer patients
29
Citations
25
References
2019
Year
Polymorphisms of the TOP2A and ERCC1 genes may be a predictive factor of toxicities and survival for chemotherapy in NSCLC patients.
| Year | Citations | |
|---|---|---|
Page 1
Page 1